Decentralized clinical trials have been gaining impetus for several years, but there is still a need to propel action and accelerate the adoption of this approach industry-wide.
In this article published in PharmaVoice, Maria Fotiu, Executive VP, Decentralized Solutions, provides her commentary on overcoming barriers to change.
Download the Full Article Below
